Screener
Exponent EXPO Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 20.2%-0.3pp | 19.4%-4.5pp | 20.6%-0.8pp | 20.6%+0.3pp | 20.5%-1.5pp | |
| Net margin | 17.7%-0.7pp | 18.1%-0.8pp | 18.2%-1.3pp | 18.3%-1.2pp | 18.3%-1.0pp | |
| Returns | ||||||
| Return on equity | 31.2%+6.2pp | 27.9%+2.1pp | 26.1%-1.9pp | 25.8%-2.1pp | 25.1%-2.9pp | |
| Return on invested capital | 31.6%+0.9pp | 29%-9.2pp | 34.8%-5.3pp | 31.1%-0.1pp | 30.7%-3.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×+0.1× | 0.8×0.0× | 0.7×0.0× | 0.8×-0.1× | 0.8×-0.1× | |
| Liquidity | ||||||
| Current ratio | 2×-1.2× | 2.4×-0.9× | 2.4×-0.3× | 2.7×-0.3× | 3.2×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×+0.1× | 0.2×+0.1× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Net debt / EBITDA | 0.1×+1.3× | -0.3×+0.9× | -1.1×+0.3× | -1×+0.2× | -1.2×-0.2× | |
| Per Share | ||||||
| Book value per share | $5.89-29.1% | $6.75-21.0% | $7.62-6.7% | $7.87-1.0% | $8.31+8.8% | |
| Valuation | ||||||
| Market capitalization | $3.21B-11.5% | $3.25B-18.9% | $3.59B-22.9% | $3.58B-25.3% | $3.5B-34.9% | |
| Price / earnings | 28.7×-6.5× | 29.9×-8.1× | 33.8×-8.8× | 34.1×-10.9× | 34×-17.2× | |
| Price / sales | 5.1×-1.4× | 5.4×-1.8× | 6.2×-2.2× | 6.3×-2.5× | 6.2×-3.7× | |
| Price / book | 11.1×+2.6× | 9.6×+0.5× | 9.2×-1.9× | 8.9×-2.8× | 8.2×-5.5× | |
| EV / EBITDA | 23.4×-4.5× | 25.3×-1.5× | 26.5×-8.1× | 27×-11.7× | 26.9×-14.0× | |
| Dividend yield | 1.9%+0.3pp | 1.9%+0.4pp | 1.7%+0.5pp | 1.7%+0.5pp | 1.7%+0.7pp |
FAQ
- Where do Exponent's ratios come from?
- Every ratio is computed from Exponent's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
